0001567619-22-013139.txt : 20220617
0001567619-22-013139.hdr.sgml : 20220617
20220617212734
ACCESSION NUMBER: 0001567619-22-013139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grais Linda
CENTRAL INDEX KEY: 0001413306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 221025770
MAIL ADDRESS:
STREET 1: 86 ALEJANDRA AVE
CITY: ATHERTON
STATE: CA
ZIP: 94027
FORMER NAME:
FORMER CONFORMED NAME: Grais Linda S
DATE OF NAME CHANGE: 20070924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc1.xml
FORM 4
X0306
4
2022-06-15
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001413306
Grais Linda
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
1
0
0
0
Stock Option (Right to Buy)
0.9899
2022-06-15
4
A
0
15000
0.00
A
2032-06-15
Common Stock
15000
15000
D
The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
/s/ Leiv Lea, as Attorney-in-Fact for Linda S. Grais
2022-06-17